Dr. Martens (LON:DOCS) Reaches New 12-Month High - Here's Why

Key Points

• Dr. Martens' stock reached a new 52-week high of GBX 96.90 ($1.30) on Tuesday, trading volume totaled 2,529,910 shares.
• Analysts have provided mixed ratings with Peel Hunt upgrading the stock to "buy" while the consensus rating remains a "hold" with an average target price of GBX 6,000.
• Insider activity revealed that insider Giles Wilson sold 30,000 shares at an average price of GBX 91, while insiders collectively purchased 136,800 shares valued at over $12.4 million in the last quarter.

Dr. Martens plc (LON:DOCS - Get Free Report)'s stock price reached a new 52-week high on Tuesday . The stock traded as high as GBX 96.90 ($1.30) and last traded at GBX 96.90 ($1.30), with a volume of 2529910 shares trading hands. The stock had previously closed at GBX 95.55 ($1.28).

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on DOCS shares. Peel Hunt upgraded shares of Dr. Martens to a "buy" rating in a report on Monday, August 18th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating on shares of Dr. Martens in a report on Friday, July 11th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Dr. Martens presently has a consensus rating of "Hold" and an average target price of GBX 6,000.

Dr. Martens Stock Up 1.9%

The business's 50 day moving average price is GBX 86.11 and its 200-day moving average price is GBX 70.54. The firm has a market capitalization of £940.08 million, a PE ratio of 19,470.00, a P/E/G ratio of 6.40 and a beta of 0.11. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85.

Insider Activity

In other news, insider Giles Wilson sold 30,000 shares of the business's stock in a transaction that occurred on Monday, September 1st. The shares were sold at an average price of GBX 91, for a total value of £27,300. Over the last quarter, insiders have purchased 136,800 shares of company stock valued at $12,437,769. 2.76% of the stock is currently owned by insiders.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.